Living biotherapeutic product - Ginkgo Bioworks/Tantu Therapeutics
Latest Information Update: 29 Sep 2021
At a glance
- Originator Tantu Therapeutics
- Class Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Gastrointestinal disorders; Inflammatory bowel diseases